Y. Tomono

发表

Population pharmacokinetics of the 5‐hydroxymethyl metabolite of tolterodine after administration of fesoterodine sustained release tablet in western and east Asian populations

B. Malhotra, M. Oishi, Y. Tomono, 2014, Journal of clinical pharmacology.

Statistical Analyses in Clinical PPK/PD Studies

Y. Tomono, 2000 .

A Phase I Study of E-1020, a New Positive Inotropie Agent

H. Hayakawa, Y. Tomono, H. Sasaki, 1990 .

A Phase I Study of E-1020

H. Hayakawa, H. Atarashi, Y. Tomono, 1990 .

Pharmacokinetic properties of E3810, a new proton pump inhibitor, in healthy male volunteers.

A. Ohnishi, Y. Tomono, J. Hasegawa, 1994, International journal of clinical pharmacology and therapeutics.

Aquaretic effect of the stable dynorphin-A analog E2078 in the human.

A. Ohnishi, T. Tanaka, Y. Tomono, 1994, The Journal of pharmacology and experimental therapeutics.

Antacids have no influence on the pharmacokinetics of rabeprazole, a new proton pump inhibitor, in healthy volunteers.

Y. Tomono, S. Yasuda, M. Kawaguchi, 1999, International journal of clinical pharmacology and therapeutics.

Population pharmacokinetic modelling of factor IX activity after administration of recombinant factor IX in patients with haemophilia B

J. Korth-Bradley, Y. Tomono, A. Suzuki, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Plasma Concentrations of Lidocaine and Its Principal Metabolites during Intermittent Epidural Anesthesia

R. Inoue, T. Ishizaki, H. Echizen, 1985, Anesthesiology.

Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairment.

S. Shoji, S. Marshall, E. Soto, 2014, British journal of clinical pharmacology.

Comparison of the kinetic disposition and metabolism of E3810, a new proton pump inhibitor, and omeprazole in relation to S‐mephenytoin 4′‐hydroxylation status

Kaoru Kobayashi, K. Chiba, T. Ishizaki, 1995, Clinical pharmacology and therapeutics.

Population Pharmacokinetic Analysis of Voriconazole from a Pharmacokinetic Study with Immunocompromised Japanese Pediatric Subjects

S. Shoji, Ping Liu, Y. Tomono, 2015, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy male volunteers.

A. Ohnishi, Y. Tomono, J. Hasegawa, 1993, International journal of clinical pharmacology, therapy, and toxicology.

Effect of dietary fat content on oral bioavailability of menatetrenone in humans.

T. Sassa, M. Niwa, Toshihiko Uematsu, 1996, Journal of pharmaceutical sciences.

Study of the Pharmacokinetic Dose-Linearity of a Sustained-Release Formulation of Bunazosin (E1015) in Healthy Volunteers

Y. Tomono, N. Morishita, 1993 .

Pharmacokinetic study of deuterium-labelled coenzyme Q10 in man.

T. Seki, K. Motegi, Y. Tomono, 1986, International journal of clinical pharmacology, therapy, and toxicology.

Phase I Study of Flecainide Acetate (E0735) Injection

E. Takamura, H. Hayakawa, H. Atarashi, 1996 .

Population pharmacokinetics of pregabalin in healthy subjects and patients with post-herpetic neuralgia or diabetic peripheral neuropathy.

Shigeyuki Matsui, Yoshiro Tomono, Misaki Suzuki, 2011, British journal of clinical pharmacology.

Bioequivalence and Pharmacokinetics of a New Theophylline Slow Release Formulation, E-0686

Setsuo Kobayashi, Y. Tomono, J. Hasegawa, 1985 .

Influence of Concomitant Administrations on the Clearance of Theophylline as Analyzed by Population Pharmacokinetics

K. Ohashi, Y. Tomono, M. Tateishi, 2001 .

Different truncation methods of AUC between Japan and the EU for bioequivalence assessment: influence on the regulatory judgment.

M. Oishi, Y. Tomono, T. Suwa, 2012, Drug metabolism and pharmacokinetics.

Absorption, Elimination and Metabolic Fate of Bunazosin in 3 Healthy Male Volunteers

Y. Tomono, J. Hasegawa, T. Yuzuriha, 1993 .

Usefulness of Isosorbide Dinitrate Spray as an Angina Attack Relieving Agent

J. Azuma, N. Awata, K. Hiramori, 1987 .

[A new anti-mycobacterial agent, rifabutin].

M. Abe, Y. Tomono, A. Kurashima, 2010, Kekkaku : [Tuberculosis].

Phase I Study of E1077, a Novel Parenteral Cephem Antibiotic

M. Nakashima, H. Inaba, Y. Tomono, 1994, Journal of clinical pharmacology.

A New Approach to the Drug Evaluation

Hiroshi Tanaka, Yuichi Koike, Yoshiro Tomono, 1996 .

Pharmacokinetics of a novel ACAT inhibitor, E5324, in healthy volunteers

N. Nakaya, N. Nakamichi, Y. Tomono, 1994 .

Effect of a novel ACAT inhibitor, E5324, on serum lipids and lipoproteins in healthy volunteers

N. Nakaya, N. Nakamichi, Y. Tomono, 1994 .

Comparison of the Pharmacokinetics of E2020, A New Compound for Alzheimer's Disease, in Healthy Young and Elderly Subjects

A. Ohnishi, Y. Tomono, J. Hasegawa, 1993, Journal of clinical pharmacology.

Comparison of the interaction potential of a new proton pump inhibitor, E3810, versus omeprazole with diazepam in extensive and poor metabolizers of S‐mephenytoin 4′‐hydroxylation

K. Chiba, T. Ishizaki, E. Koyama, 1995, Clinical pharmacology and therapeutics.

Population Pharmacokinetics and Pharmacodynamics Analysis after a Single Intravenous Administration of Flecainide Acetate

H. Hayashi, M. Yokota, H. Inagaki, 1997 .